SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has received Orphan Drug Designation and Rare Pediatric Disease Design ...

SGT-501 is a novel gene therapy for rare, life-threatening, genetic arrhythmogenic disease with no approved therapies - - SGT-501 has rec ...

dPhD National Program in One Health Approaches to Infectious Diseases and Life Science Research, Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, ...

Researchers successfully freeze light into a supersolid, a groundbreaking discovery with potential applications in quantum computing and energy transport.

As part of this work, researchers from the G. d'Annunzio Chieti-Pescara University and the University of Pavia (Italy) carried out a longitudinal study with 88 mothers without a clinical diagnosis, ...

The Director General visited a number of academic institutions to launch or strengthen joint research projects with the IAEA. He delivered the Lectio Magistralis at the University of Pavia, one of ...

BACKGROUND: Desmosomal gene variants (DGVs) have been associated with a diverse spectrum of phenotypic manifestations within arrhythmogenic cardiomyopathy, but data on genotype-specific outcomes are ...

Fortunately, with integrated photonics it is possible to do just that — make efficient, robust and stable sources of entangled photon pairs. In an invited paper published in the journal PRX Quantum, ...

Mattia Cordioli (b. 1993, Italy) obtained his Bachelor's degree in Bioengineering at the University of Pavia, Italy in 2015. He obtained a Master's degree in Bioengineering at the University of Pavia, ...

"The world record holder performed a cycling test and knee extensor exercises in the lab of Simone Porcelli, MD, PhD, at the University of Pavia in Italy. The goal of the exercise session was to ...